Quarter-over-quarter and year-over-year time series from SEC company facts — every whitelisted metric with deltas, ratios, and anomaly flags.
Coverage
20 of 25 metrics reported
5 not in filing history
Selected
$130M
2026-03-31 · quarterly · YoY 12.0%
| Period end | Frequency | Value | QoQ | YoY | Flag |
|---|---|---|---|---|---|
| 2026-03-31 | quarterly | $130M | -71.2% | +12.0% | |
| 2025-09-30 | quarterly | $449M | +53.6% | +47.2% | |
| 2025-06-30 | quarterly | $292M | +108.2% | +46.0% | Anomaly |
| 2025-03-31 | quarterly | $140M | -61.8% | +21.4% | |
| 2024-09-30 | quarterly | $368M | +55.5% | +20.5% | |
| 2024-06-30 | quarterly | $236M | +104.5% | +18.1% | Anomaly |
| 2024-03-31 | quarterly | $116M | -62.1% | +21.1% | |
| 2023-09-30 | quarterly | $305M | +52.4% | +10.0% | |
| 2023-06-30 | quarterly | $200M | +109.6% | +14.1% | Anomaly |
| 2023-03-31 | quarterly | $95M | -65.6% | +24.0% | |
| 2022-09-30 | quarterly | $277M | +58.1% | +56.9% | |
| 2022-06-30 | quarterly | $175M | +127.8% | +51.7% | Anomaly |
| 2022-03-31 | quarterly | $77M | -56.5% | +42.0% | |
| 2021-09-30 | quarterly | $177M | +52.9% | +193.9% | |
| 2021-06-30 | quarterly | $116M | +113.3% | +446.5% | Anomaly |
| 2021-03-31 | quarterly | $54M | -9.9% | — | |
| 2020-09-30 | quarterly | $60M | +184.3% | — | Anomaly |
| 2020-06-30 | quarterly | $21M | — | — |
revenue · magnitude 184.3%
revenue · magnitude 2186.1%
revenue · magnitude 113.3%
revenue · magnitude 139.7%
revenue · magnitude 127.8%
revenue · magnitude 109.6%
revenue · magnitude 104.5%
revenue · magnitude 108.2%
| Metric | Status | Annual | Quarterly | Gaps |
|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | reported | 7 | 18 | 6 |
| Cost Of Goods And Services Sold | reported | 0 | 6 | 0 |
| Gross Profit | not reported | 0 | 0 | 0 |
| Research And Development Expense | reported | 7 | 18 | 6 |
| Selling General And Administrative Expense | not reported | 0 | 0 | 0 |
| Operating Income Loss | reported | 1 | 1 | 0 |
| Net Income Loss | reported | 7 | 18 | 6 |
| EPS Basic | reported | 7 | 18 | 6 |
| EPS Diluted | reported | 7 | 18 | 6 |
| Cash And Cash Equivalents At Carrying Value | reported | 8 | 25 | 10 |
| Accounts Receivable Net Current | not reported | 0 | 0 | 0 |
| Inventory Net | not reported | 0 | 0 | 0 |
| Assets Current | reported | 1 | 2 | 0 |
| Assets | reported | 6 | 23 | 16 |
| Liabilities Current | reported | 1 | 3 | 1 |
| Long Term Debt Non-current | not reported | 0 | 0 | 0 |
| Liabilities | reported | 6 | 22 | 13 |
| Stockholders Equity | reported | 9 | 27 | 19 |
| Net Cash Provided By Used In Operating Activities | reported | 7 | 18 | 6 |
| Net Cash Provided By Used In Investing Activities | reported | 7 | 18 | 6 |
| Net Cash Provided By Used In Financing Activities | reported | 7 | 18 | 6 |
| Entity Common Stock Shares Outstanding | reported | 6 | 15 | 5 |
| Weighted Average Number Of Shares Outstanding Basic | reported | 7 | 18 | 6 |
| Weighted Average Number Of Diluted Shares Outstanding | reported | 7 | 18 | 6 |
| Common Stock Shares Authorized | reported | 6 | 21 | 13 |